Yuta Tamemoto a, Yukihiro Shibata a b, Natsumi Hashimoto a, Hiromi Sato a, Akihiro Hisaka. Involvement of multiple cytochrome P450 isoenzymes in drug interactions between ritonavir and direct oral anticoagulants. Drug Metab Pharmacokinet, 53, 100498 (2023) (IF=2.1) doi: 10.1016/j.dmpk.2023.100498.
Jessica Anindita, Hiroki Tanaka, Ryotaro Oyama, Shinya Hagiwara, Daiki Shirane, Sakura Taneichi, Yuta Nakai, Kota Tange, Hiroto Hatakeyama, Yu Sakurai, Hidetaka Akita. Development of a Ready-to-Use-type RNA vaccine carrier based on an intracellular environment-responsive lipid-like material with immune-activating vitamin E-scaffolds. Pharmaceutics, 15(12), 2702 (2023) (IF=5.4)
Hiroto Hatakeyama. Elucidation of pharmacokinetic factors affecting the efficacy of immune checkpoint inhibitors. JSP/CSPS Joint Symposium, the 143rd Annual Meeting of the Pharmaceutical Society of Japan. March, 25, 2023. Sapporo.
Hiroto Hatakeyama. Elucidation of pharmacokinetic factors affecting the efficacy of immune checkpoint inhibitors. Faculty of Pharmacy and Pharmaceutical Sciences Seminar Series, the University of Alberta. May 23, 2023. Edmonton, Alberta, Canada
Hiroto Hatakeyama. Elucidation of pharmacokinetic factors affecting the efficacy of immune checkpoint inhibitors. Canadian Society of Pharmaceutical Sciences (CSPS) Annual Symposium. May 26, 2023. Toronto, Ontario, Canada.
Hiroto Hatakeyama. Re-thinking of delivery strategy of biologics and nano DDSto tumor: beyond the EPR effect. 2023 ICCP/JSSX International Joint Meeting. September 26, 2023. Shizuoka
Hiroto Hatakeyama. Exploring of pharmacokinetic factors affecting the efficacy and adverse events of immune checkpoint inhibitors. 2023 ICCP/JSSX International Joint Meeting. September 28, 2023. Shizuoka ※奨励賞受賞講演